<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

CGM users see more time in range during early weeks of COVID-19 pandemic

Default sub title

minute read

by Healio | February 15, 2021
placeholder

Most people with diabetes who used continuous glucose monitoring during the first 8 weeks of the COVID-19 pandemic improved their time in range, although the benefits varied by region and socioeconomic status, according to study data.

Topics: Press Coverage